What comes next for COVID booster shots after the FDA panel hedges on Pfizer

But that certainly doesn't put the kibosh on widespread COVID boosters indefinitely. The question has never been if boosters should win a regulatory blessing, but rather when, for whom, and with what level of urgency.

from Google Alert - Business https://ift.tt/3khegVA
But that certainly doesn't put the kibosh on widespread COVID boosters indefinitely. The question has never been if boosters should win a regulatory blessing, but rather when, for whom, and with what level of urgency. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize